48 Weeks pegylated interferon alfa-2a is superior to 24 weeks of pegylated interferon alfa-2b in achieving HBeAg seroconversion in chronic hepatitis B infection

被引：0
|
作者：
Lai, Lawrence S. W.
Fung, Tang-Tat
Lai, Sik-To
Yiu, Jak
Lam, Polly
Zhang, Hai-Ying
Wong, Wai-Man
Lo, Chung-Mau
Fan, Sheung-Tat
Hui, Chee-Kin
Leung, Nancy
Lau, George K. K.
机构：
[1] Caritas Med Ctr, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Kwong Wah Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[3] Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Queen Elizabeth Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
[5] Univ Hong Kong, Queen Elizabeth Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[6] Univ Hong Kong, Ctr Study Liver Dis, Hong Kong, Hong Kong, Peoples R China
[7] St Pauls Hosp, Hong Kong, Hong Kong, Peoples R China
[8] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[9] Alice Ho Miu Ling Nethersole Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A90 / A90
页数：1
相关论文
共 50 条
  • [1] 48 Weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection
    Hui, CK
    Lai, LSW
    Lam, P
    Zhang, HY
    Fung, TT
    Lai, ST
    Wong, WM
    Lo, CM
    Fan, ST
    Leung, N
    Lau, GKK
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1171 - 1178
  • [2] Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
    Huang, Yi-Wen
    Hsu, Chao-Wei
    Lu, Sheng-Nan
    Yu, Ming-Lung
    Su, Chien-Wei
    Su, Wei-Wen
    Chien, Rong-Nan
    Hsu, Ching-Sheng
    Hsu, Shih-Jer
    Lai, Hsueh-Chou
    Qin, Albert
    Tseng, Kuan-Chiao
    Chen, Pei-Jer
    HEPATOLOGY INTERNATIONAL, 2020, 14 (06) : 997 - 1008
  • [3] Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
    Yi-Wen Huang
    Chao-Wei Hsu
    Sheng-Nan Lu
    Ming-Lung Yu
    Chien-Wei Su
    Wei-Wen Su
    Rong-Nan Chien
    Ching-Sheng Hsu
    Shih-Jer Hsu
    Hsueh-Chou Lai
    Albert Qin
    Kuan-Chiao Tseng
    Pei-Jer Chen
    Hepatology International, 2020, 14 : 997 - 1008
  • [4] 24 weeks of monotherapy with pegylated interferon alfa-2b in patients with acute hepatitis C.
    Wiegand, J
    Boecher, W
    Buggisch, P
    Zeuzem, S
    Gelbmann, CM
    Cornberg, M
    Jäckel, E
    Wedemeyer, H
    Manus, MP
    HEPATOLOGY, 2003, 38 (04) : 277A - 277A
  • [5] Comparison of pegylated interferon alfa-2a and alfa-2b in combination with ribavirin in obese patients with chronic hepatitis
    Moore, CH
    Angtuaco, TL
    Lindsey, JL
    Nelson, SD
    Malik, AH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S109 - S109
  • [6] Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C
    Jen, JF
    Glue, P
    Ezzet, F
    Chung, C
    Gupta, SK
    Jacobs, S
    Hajian, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (06) : 407 - 421
  • [7] Pegylated interferon alfa-2b (PEG-Intron) monotherapy is superior to interferon alfa-2b (Intron A) for the treatment of chronic hepatitis C
    Trepo, C
    Lindsay, K
    Niederau, C
    Shiffman, M
    Gordon, S
    Hoefs, J
    Schiff, E
    Marcellin, P
    Bacon, B
    Fang, J
    Garaud, J
    Albrecht, J
    JOURNAL OF HEPATOLOGY, 2000, 32 : 29 - 29
  • [8] PEGYLATED INTERFERON ALFA-2A THERAPY FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B IN TAIWAN
    Lai, Hsueh-Chou
    Peng, Cheng-Yuan
    Su, Wen-Pang
    Chuang, Po-Heng
    HEPATOLOGY, 2010, 52 (04) : 549A - 549A
  • [9] Pegylated interferon alfa-2a therapy for HBeAg-negative chronic hepatitis B in Taiwan
    Lai, H. C.
    Peng, C. Y.
    Su, W. P.
    Chuang, P. H.
    Kao, J. T.
    Chou, J. W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A175 - A175
  • [10] Thyrotoxicosis With Pegylated Interferon Alfa-2b
    Lowndes, Sarah A.
    Asher, Ruth
    Middleton, Mark R.
    ARCHIVES OF DERMATOLOGY, 2010, 146 (11) : 1273 - 1275
12345